We offer a variety of customizable packages for the development of monoclonal antibodies and hybridomas to make your project run smoothly and in a cost effective manner. Our monoclonal antibodies are produced in an AAALAC International accredited and OLAW assured animal facility.
Our MonoExpress™ services generate specific hybridoma supernatants within 45 days after antigen preparation, allowing you to evaluate the supernatant or use it right away. These packages deliver custom monoclonal antibodies quickly and with a range of costs and guarantees to meet a variety of application needs.
Custom phospho-specific monoclonal antibodies come with a success rate of over 95%, guaranteed ELISA titer of ≥1:64,000 and up to 5 positive hybridomas, allowing you on-demand production of your monoclonal antibodies.
These customizable development packages for monoclonal antibodies are ideal if the predefined monoclonal antibody services do not meet your special need.
Our specialized scale-up, purification, and modification services for monoclonal antibodies sidestep the bottleneck of monoclonal antibody production in the pharmaceutical process. Both in vivo ascites production service and in vitro roller bottle production services are available.
Monoclonal antibodies are produced in mammalian cell expression systems (CHO or 293 cells) allowing for production of large quantities of monoclonal antibodies. A 50mg quantity of custom monoclonal antibody is guaranteed or the service is free.
Monoclonal antibody sequencing allows you to protect and preserve your precious hybridoma cell lines or crucial monoclonal antibodies. Stable cell lines for the production of proteins, monoclonal antibodies, growth factors, or other soluble proteins are established for expression or for assay development.
Monoclonal antibody modification and other services including conjugation, fluorolabeling, purification, special modifications, and immunoassay development are offered.
Custom anti-idiotype polyclonal and monoclonal antibodies are produced for vaccine development, pharmacokinetic (PK), and immunogenicity (anti-drug antibody) assays. Deliverables include frozen cells, live cells, and culture supernatant with optional cell storage service.
GenScript has established a comprehensive monoclonal antibody drug development platform that can smoothly integrate antibody engineering and monoclonal antibody production technologies to satisfy your needs in drug development.
Key Features of Monoclonal Antibody Services
Our customer service representatives are available 24 hours a day, Monday through Friday to assist you.